Even though peers were trading 70-100 million market caps after pre clinical success the Share price will rerate and multi bag in a day leading from GLP to Walter Reed and phase 1 completion, leading to phase 2 and into FDA phase 2 which the company is fully funded. Big quarter ahead and the directors have filled themselves up which shows you the confidence.
Let the news flow fall shortly
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-170
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.028(32.2%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $296.2K | 2.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 175032 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |